What is Corvus Pharmaceuticals's short-term investments?

Corvus Pharmaceuticals (CRVS) reported short-term investments of $196.61M in Q1 2026.

What does short-term investments mean?

Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Corvus Pharmaceuticals CRVS Short-Term Investments

Short-Term Investments at other companies

Regeneron PharmaceuticalsREGN

$5.79B+10.1%

Avalo TherapeuticsAVTX

$57.01M—

Cullinan Therapeutics, Inc.CGEM

$276.8M+21.8%

Arcus BiosciencesRCUS

$621M-22.9%

Nektar TherapeuticsNKTR

$419.03M+133%

Iovance Biotherapeutics, Inc.IOVA

$116.94M-37.8%

Other financials

Income statement

See full

Operating income-$14.9M-49.9%

Net income-$13.7M-190%

EPS (diluted)-$0.15-15.4%

Balance sheet

See full

Cash & equivalents$40.1M+702%

Total debt$834.0K-27.7%

Total equity$240.7M+388%

Total assets$253.2M+326%

Cash flow

See full

Operating cash flow-$10.4M-25.5%

CapEx$91.0K+153%

Free cash flow-$10.5M-26.1%

Valuation

See full

Market cap$1.1B+259%

Enterprise value$1.06B+251%

Returns & leverage

See full

Return on equity-30.5%-12.5pp

Debt / equity0×0.0×

Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvus Pharmaceuticals's short-term investments?: Corvus Pharmaceuticals (CRVS) reported short-term investments of $196.61M in Q1 2026.
What does short-term investments mean?: Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.